NFKB1 and urinary bladder carcinoma: Additionally, TRIM29 is overexpressed in bladder cancer tissues, where it promotes tumor progression by activating the protein kinase C (PKC) and NF-κB pathway, thereby inhibiting cancer cell apoptosis.